Disease Info Card

Waardenburg Syndrome, Type I (disorder)

Information about Waardenburg Syndrome, Type I (disorder): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Waardenburg Syndrome, Type I (disorder)

Most recent studies have shown that Waardenburg Syndrome, Type I (disorder) shares some biological mechanisms with albinism, carcinoma, catatrichy, complete-hearing-loss, crest-syndrome, deafness-congenital, diabetes-mellitus, hereditary-diseases, hirschsprung-disease, hypopigmentation-disorder, hypoplasia, kleins-syndrome, malignant-neoplasms, piebaldism, pigmentation-disorders, sensorineural-hearing-loss-(disorder), spina-bifida, waardenburg-syndrome, waardenburg-syndrome-type-2, white-forelock.

Among the many pathways, these few ones have gauged particular interests from scientists studying Waardenburg Syndrome, Type I (disorder), and have been seen in publications frequently: Aging, Cell Adhesion, Cell Death, Cell Development, Cell Migration, Cell Proliferation, Embryo Development, Fibroblast Migration, Neural Crest Cell Development, Neural Crest Cell Migration, Neural Tube Closure, Neurogenesis, Pigmentation, Protein Phosphorylation, Proteolysis, Response To Wounding, Secretion, Transport, Tube Formation, Wound Healing

Quite a number of genes have been found to play important roles in Waardenburg Syndrome, Type I (disorder), such as ALPP, DCTN6, EDN3, EDNRB, ELN, FN1, IL6, KIT, MITF, PAX3, SNAI2, SOX10, SS18L1, TFF2, TNF, TNFRSF25, TYR. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.